SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021438
Filing Date
2022-11-03
Accepted
2022-11-02 20:29:53
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20220930.htm   iXBRL 10-Q 2553122
2 EX-10.1 acad-ex10_1.htm EX-10.1 417306
3 EX-10.2 acad-ex10_2.htm EX-10.2 20562
4 EX-10.3 acad-ex10_3.htm EX-10.3 187013
5 EX-31.1 acad-ex31_1.htm EX-31.1 13862
6 EX-31.2 acad-ex31_2.htm EX-31.2 14103
7 EX-32.1 acad-ex32_1.htm EX-32.1 10174
8 EX-32.2 acad-ex32_2.htm EX-32.2 10218
  Complete submission text file 0000950170-22-021438.txt   9434412

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20220930_def.xml EX-101.DEF 113041
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20220930_lab.xml EX-101.LAB 332474
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acad-20220930_cal.xml EX-101.CAL 52913
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20220930_pre.xml EX-101.PRE 244910
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20220930.xsd EX-101.SCH 41774
56 EXTRACTED XBRL INSTANCE DOCUMENT acad-20220930_htm.xml XML 1964174
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 221355831
SIC: 2834 Pharmaceutical Preparations